Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot study. (Q39399592)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

title

Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

Dragana Nikolić

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

Giuseppe Montalto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Rosaria Vincenza Giglio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

Angelo Maria Patti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

Claudia Campanella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

Massimo Cocchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

Niki Katsiki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

publication date

18 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

538-542

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

Dietary chitosan inhibits hypercholesterolaemia and atherogenesis in the apolipoprotein E-deficient mouse model of atherosclerosis

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Improvement of HDL- and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

A meta-analysis evaluating the impact of chitosan on serum lipids in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

There is more to predicting vascular disease than just established risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Should we measure routinely the LDL peak particle size?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Interaction of low density lipoproteins with arterial proteoglycans. The role of charge and sialic acid content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

An Evidence-Based Review of Fat Modifying Supplemental Weight Loss Products

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Effect of Chitosan, O-Carboxymethyl Chitosan, and N-[(2-Hydroxy-3-N,N-dimethylhexadecyl ammonium)propyl] Chitosan Chloride on Overweight and Insulin Resistance in a Murine Diet-Induced Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Chitosan ameliorates the severity of steatohepatitis induced by high fat diet in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Insulin Resistance, Hyperglycemia, and Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Should adipokines be considered in the choice of the treatment of obesity-related health problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

The role of fibrate treatment in dyslipidemia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0003319713493126

21 January 2018

Identifiers

DOI

10.1177/0003319713493126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23785043 AND SRC:MED&resulttype=core&format=json

3 March 2020

1 reference